SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
遺伝子特許に関する米国連邦最高裁判決の意義[Ass'n for Molecular Pathology (AMP) v. Myriad Genetics, Inc., 133 S. Ct. 2107, 186 L. Ed. 2d 124 (2013)]
0 references·5 citing·15 second hop
遺伝子特許に関する米国連邦最高裁判決の意義[Ass'n for Molecular Pathology (AMP) v. Myriad Genetics, Inc., 133 S. Ct. 2107, 186 L. Ed. 2d 124 (2013)] (2013)遺伝子特許に関する米国連邦最高裁判決の意義[Ass'n for Molecular…Continental drift? Do European clinical genetic testing laboratories have a patent problem? (2019)Continental drift? Do Europea…Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts? (2018)Was the Myriad decision a 'su…Intellectual property rights derived from academic research and their role in the modern bioeconomy—A guide for scientists (2017)Intellectual property rights …Persistent confusion and controversy surrounding gene patents (2016)Persistent confusion and cont…Myriad's impact on gene patents (2016)Myriad's impact on gene paten…A Cross-Atlantic Dialog on Experimental Use and Research Tools (2007)Teaching and Assessing the Responsible Conduct of Research: A Delphi Consensus Panel Report. (2009)Markets for Technology (2001)Patents in Genomics and Human Genetics (2010)Markets for Technology (2013)International Divergence in Gene Patenting (2019)European patent protection for medical uses of known products and drug repurposing (2022)The Philosophy of Intellectual Property (2003)Columbia University's Axel Patents: Technology Transfer and Implications for the Bayh‐Dole Act (2009)Changing R&D models in research-based pharmaceutical companies (2016)The History of Patenting Genetic Material (2015)After Myriad, what makes a gene patent claim 'markedly different' from nature? (2017)Effects of Patents and Licenses on the Provision of Clinical Genetic Testing Services (2003)Probabilistic Patents (2005)Where excludability matters: Material versus intellectual property in academic biomedical research (2007)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2016Myriad's impact on gene patents19 cited
  • 2017Intellectual property rights derived from academic research and their role in the modern bioeconomy—A guide for scientists16 cited
  • 2019Continental drift? Do European clinical genetic testing laboratories have a patent problem?15 cited
  • 2018Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?12 cited
  • 2016Persistent confusion and controversy surrounding gene patents8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work